Monday, September 29, 2014

ALIM: Alimera Sciences Provides Details On FDA Approval Of ILUVIEN(R) As The First Long-Term Treatment For Diabetic Macular Edema

New alert via PocketInfo for ALIM:

Alimera Sciences Provides Details On FDA Approval Of ILUVIEN(R) As The First Long-Term Treatment For Diabetic Macular Edema

Press Releases: http://investor.alimerasciences.com/releases.cfm
SEC Filings: http://investor.alimerasciences.com/sec.cfm
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8

No comments:

Post a Comment